Skip to main content
. 2023 Jan 3;24:3. doi: 10.1186/s13063-022-07010-4

Table 2.

Participants’ underlying disease

Primary diagnosis l-Carnitine group (n=24) Control group (n=27) P-value1
Respiratory diseases 12 (50) 8 (29.6) 0.13
Hypertension 10 (41.7) 13 (48.1) 0.64
Cardiovascular diseases 10 (41.7) 17 (63) 0.128
Central nervous system problems 8 (33.3) 9 (33.3) >0.99
Diabetes 7 (29.2) 7 (25.9) 0.79
Stroke 5 (20.8) 8 (29.6) 0.47
Cancer 4 (16.7) 3 (11.1) 0.56
Gastrointestinal disease 3 (12.5) 3 (11.1) 0.87

1Chi-squared test